According to FutureWise analysis, the autoimmune disease therapeutics market in 2026 is US$ 164.73 billion and is expected to reach US$ 229.18 billion by 2036 at a CAGR of 3.36%.
The autoimmune disease therapeutics market is substantial and includes treatments for various conditions such as rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease, and psoriasis, among others. Biologic drugs, particularly monoclonal antibodies and TNF inhibitors, dominate this market because of their targeted mechanisms of action and greater efficacy compared to traditional immunosuppressants. The growing global prevalence of autoimmune disorders—driven by factors like environmental triggers, lifestyle changes, and improved diagnostic capabilities—continues to increase the demand for innovative therapies. Additionally, biosimilars are gaining market share as patents for major biologic drugs expire, providing more affordable treatment options and expanding patient access, especially in price-sensitive markets. Pharmaceutical companies are investing significantly in next-generation therapies, including JAK inhibitors, IL-17 blockers, and personalized medicine approaches that target specific immune pathways. These advancements aim to improve treatment outcomes while minimizing side effects.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Autoimmune Disease Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Autoimmune Disease Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.